Patents by Inventor Isabelle Thielemans

Isabelle Thielemans has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5741806
    Abstract: The invention relates to a pharmaceutical composition for rectal administration which comprises 1,2,3,9-tetrahydro-9-methyl-3-?(2-methyl-1H-imidazol-1-yl)- methyl!-4H-carbazol-4-one in the form of its free base or a pharmaceutically acceptable solvate thereof as active ingredient, together with one or more pharmaceutically acceptable carriers or excipients. Methods for the manufacture of such compositions and for their use in the treatment of conditions mediated through the action of 5-hydroxytryptamine at 5-HT.sub.3 receptors are also described.
    Type: Grant
    Filed: December 4, 1995
    Date of Patent: April 21, 1998
    Assignee: Laboratoire Glaxo Wellcome S.A.
    Inventors: Isabelle Thielemans, Isabelle Richard
  • Patent number: 5705506
    Abstract: The present invention relates to a pharmaceutical composition for rectal administration in solid dosage form which comprises a compound acting as a 5HT-1 like receptor agonist in the form of its free base or a physiologically acceptable hard fat base carrier having a hydroxyl value of more than 15 in the method for the treament of a mammal suffering from a susceptible to conditions associated with cephalic pain.
    Type: Grant
    Filed: December 29, 1994
    Date of Patent: January 6, 1998
    Assignee: Laboratoires Glaxo SA
    Inventors: Nadine Merlet, Isabelle Richard, Isabelle Thielemans